* Hospitalizations are down 26 percent from a week ago, ICU usage is down 27 percent, the test positivity rate is down 22 percent, cases are down 20 percent and deaths are down 23 percent…

The Illinois Department of Public Health (IDPH) today reported 10,462 new confirmed and probable cases of coronavirus disease (COVID-19) in Illinois, including an increase of 272 deaths since February 25, 2022.

Currently, IDPH is reporting a total of 3,037,199 cases, including 32,926 deaths, in 102 counties in Illinois. The age of cases ranges from younger than one to older than 100 years. Since February 25, 2022, laboratories have reported 750,521 specimens for a total of 55,089,500. As of last night, 843 individuals in Illinois were reported to be in the hospital with COVID-19. Of those, 153 patients were in the ICU and 77 patients with COVID-19 were on ventilators.

The preliminary seven-day statewide positivity for cases as a percent of total test from February 25 - March 3, 2022 is 1.4%. The preliminary seven-day statewide test positivity from February 25 - March 3, 2022 is 1.6%.

A total of 21,157,960 vaccines have been administered in Illinois as of last midnight. The seven-day rolling average of vaccines administered daily is 12,488 doses. Since February 25, 2022, 87,414 doses were reported administered in Illinois. Of Illinois’ total population, 76% has received at least one COVID-19 vaccine dose, more than 67% of Illinois’ total population is fully vaccinated, and more than 49% boosted according to data from the Centers for Disease Control and Prevention (CDC).

Beginning this weekend, daily deaths reported on weekends and at the beginning of the week may be low as IDPH and local health departments move away from reviewing and processing COVID-19 death records over the weekend. Those deaths will be captured in subsequent days.

All data are provisional and will change. Additional information and COVID-19 data can be found at https://dph.illinois.gov/covid19.html.

Vaccination is the key to ending this pandemic. To find a COVID-19 vaccination location near you, go to www.vaccines.gov.

* From the Atlantic…

The rush in the rich countries to declare the pandemic “over” while it continues to ravage the global South is completely predictable—in fact, the same trend has played out again and again. Infectious diseases such as malaria, tuberculosis, and HIV that are now seen as “Third World diseases” were once serious threats in rich countries, but when incidence of these diseases began to decline there, the global North moved on and reduced investments in new tools and programs. Now, with COVID-19, the developing world has once again been left to fend for itself against an extremely transmissible virus without the necessary vaccine doses, tests, and treatment tools. Some pandemics never truly end—they just become invisible to people in the global North.

You may know malaria as an infectious disease that affects poor “tropical” countries. But for several thousands of years, malaria was a global menace. During the 20th century alone, the disease is estimated to have accounted for up to 5 percent of all human deaths. It was eradicated from the global North by the 1970s, but the rest of the world was left behind. In 2020, there were an estimated 240 million malaria cases, and nearly all of the 627,000 deaths occurred in sub-Saharan Africa. For a disease that affected even our neolithic ancestors, the world had to wait until 2021 for the first-ever malaria vaccine. Though the World Health Organization recently endorsed this partially effective malaria vaccine, expanded manufacturing and scale-up plans remain undetermined.

The same phenomenon has unfolded with tuberculosis, a disease so old that DNA of TB bacteria have been identified in Egyptian mummies. “Consumption,” as TB was once called, was highly prevalent in Europe and North America. From the 1600s to the 1800s, TB caused 25 percent of all deaths in Europe. By the 1980s, TB case numbers had decreased significantly in the West, largely thanks to drug treatments and reductions in poverty. But again, TB remains a problem in developing countries (and among marginalized populations within the global North). In 2020, TB killed 1.5 million people, more than 80 percent of whom lived in low- and middle-income countries. Investments and innovations to make the disease less devastating have been scarce: For example, the TB vaccine we use today is more than 100 years old, and it has limited efficacy in adults. […]

For now, the biggest problem with the global North proclaiming that the coronavirus pandemic is “over” is that it manifests the opposite outcome. Eventually, even rich countries will bear the brunt of tuning out COVID-19. Allowing infectious diseases to circulate in any part of the world within large populations of unvaccinated people will almost surely result in the emergence of new variants that will affect all nations.

* Related…

* Illinois’ top doctor Ngozi Ezike is being wooed to lead a Chicago health system

* ‘I’m humbled that it made a significant difference’: Dr. Ezike reflects on her time as Illinois’ top doc

* The long, strange history of anti-vaccination movements